View in EDS

Open-label treatment extension of ruxolitinib cream in vitiligo: findings from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) long-term extension phase III study.

Saved in:
Bibliographic Details
Title: Open-label treatment extension of ruxolitinib cream in vitiligo: findings from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) long-term extension phase III study.
Authors: Harris, John E1 (AUTHOR), Papp, Kim (AUTHOR), Ezzedine, Khaled (AUTHOR), Sebastian, Michael (AUTHOR), Pandya, Amit G (AUTHOR), Seneschal, Julien (AUTHOR), Amster, Mark (AUTHOR), Alam, Maryam Shayesteh (AUTHOR), Forman, Seth B (AUTHOR), Zdybski, Jacek (AUTHOR)
Source: British Journal of Dermatology. Mar2026, Vol. 194 Issue 3, p591-593. 3p.
Database: Academic Search Ultimate
Description
ISSN:00070963
DOI:10.1093/bjd/ljaf485